| Uric acid and coronary artery disease, two sides of a single coin: A determinant of antioxidant system or a factor in metabolic syndrome B Bagheri, M Zargari, FM MeShKInI, KSM DInarvanD, V Mokhberi, S Azizi, ... Journal of clinical and diagnostic research: JCDR 10 (2), OC27, 2016 | 51 | 2016 |
| Life psychosocial stresses and coronary artery disease B Bagheri, F Meshkini, K Dinarvand, Z Alikhani, M Haysom, M Rasouli International journal of preventive medicine 7, 2016 | 22 | 2016 |
| Expression and clinicopathological significance of lipin‐1 in human breast cancer and its association with p53 tumor suppressor gene N Dinarvand, H Khanahmad, SM Hakimian, A Sheikhi, B Rashidi, ... Journal of cellular physiology 235 (7-8), 5835-5846, 2020 | 20 | 2020 |
| Evaluation of long-chain acyl-coenzyme A synthetase 4 (ACSL4) expression in human breast cancer N Dinarvand, H Khanahmad, SM Hakimian, A Sheikhi, B Rashidi, ... Research in pharmaceutical sciences 15 (1), 48, 2020 | 18 | 2020 |
| Histamine and Food Allergy N Dinarvand, R Azizi International Journal of Advanced Biological and Biomedical Research 8 (2 …, 0 | 3* | |
| Diabetes and Ovarian cancer: risk factors, molecular mechanisms and impact on prognosis F Karimi, N Dinarvand, M Sabaghan, O Azadbakht, S Ataee, ... Endocrine 83 (1), 1-9, 2024 | 2 | 2024 |
| Examining dyslipidaemia, metabolic syndrome and liver enzyme levels in patients with prediabetes and type 2 diabetes in population from Hoveyzeh cohort study: A case–control … N Dinarvand, B Cheraghian, Z Rahimi, S Salehipour Bavarsad, ... Endocrinology, Diabetes & Metabolism 6 (2), e401, 2023 | 2 | 2023 |
| Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics N Dinarvand, F Karimi, R Azizi, S Rastaghi, A Sheikhi, M Pourfarzam Molecular Biology Reports 50 (3), 2061-2066, 2023 | 1 | 2023 |
| Investigation of antioxidant status in coronary artery disease patients N Dinarvand, M Rasouli, F Meshkini, M Zargari Trends in Medical Sciences 1 (1), 2021 | 1 | 2021 |
| The effect of saraglitazar on TGF-β-induced smad3 phosphorylation and expression of genes related to liver fibrosis in LX2 cell line N Dinarvand, R Afarin, E Shakerian, SS Bavarsad, N Mohammadtaghvaei Molecular Biology Reports 51 (1), 541, 2024 | | 2024 |
| Curcumin and saroglitazar attenuate diet-induced nonalcoholic steatohepatitis by activating the Nrf2 pathway and suppressing ERK1/2 signaling R Afarin, N Dinarvand, H Azizi Dariuni, G Orak, B Jaberian Asl, R Azizi, ... Iranian Journal of Basic Medical Sciences, 2024 | | 2024 |
| Comparison of the anti-inflammatory and antilipidemic activity of diosmin and saroglitazar in a model of nonalcoholic fatty liver induced by a high-fat diet in Wistar rats R Afarin, N Dinarvand, BJ Asl, G Orak, E Shakerian, F Bineshfar, ... Iranian Journal of Basic Medical Sciences 27 (2), 241, 2024 | | 2024 |
| Association of the rs236918 variant of PCSK7 with the prevalence of the metabolic syndrome and its components in population from Ahvaz cohort study: A case-control study in Iran N Dinarvand, M Rahimi, H Shahbazian, MT Birgani, B Cheraghian, ... Acta Biochimica Iranica 1 (4), 196-200, 2024 | | 2024 |
| Association of the rs7903146 variant (IVS3C> T) of TCF7L2 with the prevalence of the metabolic syndrome and its components in population from Ahvaz cohort study: a case-control … M Rahimi, N dinarvand, H Shahbazian, MT Birgani, B cheraghian, ... International Journal of Diabetes in Developing Countries, 1-6, 2023 | | 2023 |
| Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis F Karimi, O Azadbakht, A Veisi, M Sabaghan, M Owjfard, E Kharazinejad, ... Medical Oncology 40 (9), 265, 2023 | | 2023 |
morteza pourfarzamClinical Biochemistry, Isfahan University of Medical Sciences, Isfahan, IranVerified email at pharm.mui.ac.ir
